Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD , RAINBOW , and RAINFALL Phase III Studies
出版年份 2021 全文链接
标题
Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from
REGARD
,
RAINBOW
, and
RAINFALL
Phase
III
Studies
作者
关键词
-
出版物
ONCOLOGIST
Volume 26, Issue 9, Pages -
出版商
Wiley
发表日期
2021-05-26
DOI
10.1002/onco.13836
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled Trial
- (2021) Zhihao Lu et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2019) Charles S Fuchs et al. LANCET ONCOLOGY
- Clinicopathological Characteristics and Prognosis of cT1N0M1 Gastric Cancer: A Population-Based Study
- (2019) Jianbo Han et al. DISEASE MARKERS
- Impact of weight loss and sarcopenia on response to chemotherapy, quality of life and survival
- (2019) Aoife M Ryan et al. NUTRITION
- Precision medicine in gastric cancer
- (2019) Patrizia Bonelli et al. World Journal of Gastrointestinal Oncology
- Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: A systemic review and meta-analysis
- (2019) Ling-Nan Zheng et al. World Journal of Clinical Cases
- Risk factors for severe weight loss at 1 month after gastrectomy for gastric cancer
- (2018) Kenki Segami et al. Asian Journal of Surgery
- Impact of body mass index on surgical outcomes of gastric cancer
- (2018) Fan Feng et al. BMC CANCER
- Prognostic Roles of Perioperative Body Mass Index and Weight Loss in the Long-Term Survival of Gastric Cancer Patients
- (2018) Young Suk Park et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer
- (2017) Toru Aoyama et al. International Journal of Clinical Oncology
- Weight Loss During Initial Chemotherapy Predicts Survival in Patients With Advanced Gastric Cancer
- (2017) Kotoe Takayoshi et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Progress in the treatment of advanced gastric cancer
- (2017) Zheyu Song et al. TUMOR BIOLOGY
- Gastric cancer, nutritional status, and outcome
- (2017) Xuechao Liu et al. OncoTargets and Therapy
- Outcome predictors for patients with stage II/III gastric cancer who undergo gastrectomy and S-1 adjuvant chemotherapy
- (2017) Yoshinori Fujiwara et al. Oncology Letters
- Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
- (2017) Charles S. Fuchs et al. Journal of Gastric Cancer
- Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
- (2016) S.-E. Al-Batran et al. ANNALS OF ONCOLOGY
- Patterns and Predictors of Weight Loss After Gastrectomy for Cancer
- (2016) Jeremy L. Davis et al. ANNALS OF SURGICAL ONCOLOGY
- Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer
- (2015) Chan-Young Ock et al. Gastric Cancer
- Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario
- (2014) Matthew Dixon et al. Gastric Cancer
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Gastric Cancer: Current Status of Diagnosis and Treatment
- (2013) Tsunehiro Takahashi et al. Cancers
- The quality of life trajectory of resected gastric cancer
- (2011) Gitonga Munene et al. JOURNAL OF SURGICAL ONCOLOGY
- A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy
- (2010) D. Kanagavel et al. ANNALS OF ONCOLOGY
- Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2
- (2010) Jennifer L. Spratlin et al. JOURNAL OF CLINICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started